Research Articles
Development of Hplc Conditions for Valid Determination of Hydrolysis Products of Cisplatin

https://doi.org/10.1021/js980287mGet rights and content

Abstract

In water, the antineoplastic drug cisplatin, cis-[PtCl2(NH3)2] (1) hydrolyses slowly to the aqua complexes cis-[Pt(NH3)2Cl(H2O)]+(2) and, to a small extent, cis-[Pt(NH3)2(H2O)2]2+(3), which are thought to play an important role in the metabolism of cisplatin. HPLC is a useful technique for monitoring 2 and 3, but only if the components of the mobile phase used in the reverse phase HPLC technique are unreactive toward these aqua complexes under the conditions of the experiment. 15N Nuclear magnetic resonance (NMR) with samples highly enriched (>98%) in 15N has been used to check the reactivity of 2 and 3 toward substances commonly used as components of the mobile phase. The results reported herein indicate that acetonitrile, often used as an organic modifier, reacts readily with 2 and 3. Methanol, also commonly employed, is much less reactive. Carboxylic acids RCO2H (R = CH3, H, CF3), which are frequently used to adjust pH of the mobile phase, also react readily with 2 and 3. Trifluoro-methanesulfonic acid (“triflic acid”), CF3SO3H, is unreactive. Neither hexanesulfonic acid nor sodium dodecyl sulfate (SDS), used as &“ion-pairing agents”, reacts significantly with 2 or 3 under the experimental conditions, but SDS gives better peak separation. Commercial SDS must, however, be purified from chloride contamination. From our studies, optimal conditions for HPLC separation of 1, 2, and 3, with a C18 stationary phase at 37 °C, require an aqueous mobile phase with 3% v/v methanol, 0.05 mM SDS, and pH 2.5 (adjusted with triflic acid). This technique was then used to measure levels of 1, 2, and 3 in ultrafiltered serum after incubation for various times with cisplatin at 37 °C.

References and Notes (30)

  • P.E. Gormley et al.

    Kinetics of cis-Dichlorodiammineplatinum

    Clin. Pharmacol. Ther.

    (1979)
  • C. Erlichman et al.

    Disposition of Total and Free Cisplatin on Two Consecutive Treatment Cycles in Patients with Ovarian Cancer

    Cancer Chemother. Pharmacol

    (1987)
  • C.J. Boreham et al.

    A 195Pt and 15N NMR Study of the Anticancer Drug, cis-Diamminedichlo-roplatinum(II), and its Hydrolysis and Oligomerization Products

    Aust. J. Chem.

    (1981)
  • T.G. Appleton et al.

    Reactions of Platinum(II) Aqua Complexes. 1. Multi-nuclear (195Pt, 15N, and 31P) NMR Study of Reactions between the cis-Diamminediaquaplatinum(II) Cation and the Oxygen-Donor Ligands Hydroxide, Perchlorate, Nitrate, Sulfate, Phosphate, and Acetate

    Inorg. Chem.

    (1984)
  • T.G. Appleton et al.

    NMR Study of Acid–Base Equilibria and Other Reactions of Ammineplatinum Complexes with Aqua and Hydroxo Ligands

    Inorg. Chem.

    (1989)
  • Cited by (0)

    Department of Chemistry.

    School of Pharmacy.

    View full text